Ibu-Lysinhexal

Ibuprofen, the active ingredient in Ibu-Lysinhexal, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It treats pain, fever and inflammation in adults and children as directed by a healthcare professional.

GNH USA supplies Ibu-Lysinhexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibu-Lysinhexal (ibuprofen) acts on inflammatory pathways to relieve several common conditions.

Pain: reduces mild to moderate pain such as headache, dental pain, or musculoskeletal discomfort. Fever: lowers elevated body temperature associated with infections or inflammatory states. Inflammation: diminishes swelling and redness in conditions like arthritis or soft‑tissue injuries.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort such as nausea, dyspepsia or abdominal pain. - Headache or dizziness. - Mild skin rash or itching. - Elevated blood pressure in some patients.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Severe allergic reactions including anaphylaxis or angioedema. - Hepatotoxicity or renal impairment with prolonged use. - Cardiovascular events such as myocardial infarction or stroke, especially with high‑dose or long‑term therapy.

Before using Ibu-Lysinhexal, consider the following safety measures. - Renal function: assess kidney health, especially in patients with chronic disease. - Gastrointestinal risk: avoid in individuals with active ulcers or a history of GI bleeding. - Cardiovascular status: use cautiously in patients with heart disease or hypertension. - Concomitant medications: review for potential interactions with anticoagulants or other NSAIDs. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Ibuprofen can affect the activity of several other medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Selective COX‑2 inhibitors: heightened gastrointestinal toxicity.

Moderate Interactions (Monitor Closely): - Antihypertensives (e.g., ACE inhibitors, diuretics): may reduce blood‑pressure‑lowering effect. - Lithium: ibuprofen can raise lithium serum concentrations. - Methotrexate: may increase methotrexate toxicity, especially at high doses.